Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > From 150 k shares in 2020 to almost 7.5 millions!

<< Previous

Bullboard Posts

Next >>

Comment by PWIB123on Oct 27, 2022 10:56pm

185 Views

Post# 35055008

RE:RE:From 150 k shares in 2020 to almost 7.5 millions!

The effective date is as of 6/30. They appear to have refiled the 13F for both periods ending 3/31 and 6/30 for some reason. It will be interesting to see if they acquired more shares in Q3 when they file an update.

LouisW wrote: I am confused. Per the filing at mid August, Morgan Stanley alreadly owns 7423777 shares. And in the latest filing, they still own 7423777 shares...meaning they didnt accumutae the shares in Q3?

https://fintel.io/so/us/thtx/morgan-stanley

But i do agree, they are aquiring the shares significantly.

scarlet1967 wrote:

12 percent increase over 800000 shares as per latest filing!

https://fintel.io/so/ca/th/morgan-stanley